Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
167
Employees167
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
167
Employees167

AKBA Key Statistics

Market cap
260.74M
Market cap260.74M
Price-Earnings ratio
-4.50
Price-Earnings ratio-4.50
Dividend yield
—
Dividend yield—
Average volume
2.59M
Average volume2.59M
High today
$1.30
High today$1.30
Low today
$1.22
Low today$1.22
Open price
$1.25
Open price$1.25
Volume
3.11M
Volume3.11M
52 Week high
$2.48
52 Week high$2.48
52 Week low
$0.7801
52 Week low$0.7801
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.